Posted by Michael Wonder on 21 Nov 2022
Getting the price right: lessons for Medicare price negotiation from peer countries
9 November 2022 - The US pays more for brand-name prescription drugs than any other country and new legislation from August 2022 gives Medicare the authority to directly negotiate certain drug prices with manufacturers starting in 2026—something the federal insurer had been prohibited from doing for its prior history.
As the US prepares for negotiations, we therefore surveyed how comparable industrialised countries use statutory requirements and procedures to negotiate brand-name drug prices.
